First report of cerebral venous thrombosis following inactivated-virus covid vaccination (Sinopharm and Sinovac)

Sajid Hameed; Ayisha Farooq Khan; Sara Khan; Mohammad Wasay

doi:10.1016/j.jstrokecerebrovasdis.2021.106298

First report of cerebral venous thrombosis following inactivated-virus covid vaccination (Sinopharm and Sinovac)

Sajid Hameed, Ayisha Farooq Khan, Sara Khan, Mohammad Wasay

Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.

Original language	English
Article number	106298
Journal	Journal of Stroke and Cerebrovascular Diseases
Volume	31
Issue number	3
DOIs	https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106298
Publication status	Published - Mar 2022

Keywords

CVT
Cerebral venous thrombosis
Sinopharm
Sinovac
Vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jstrokecerebrovasdis.2021.106298

Cite this

@article{9066190bc3924462885b2f5a455abc50,

title = "First report of cerebral venous thrombosis following inactivated-virus covid vaccination (Sinopharm and Sinovac)",

abstract = "Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.",

keywords = "CVT, Cerebral venous thrombosis, Sinopharm, Sinovac, Vaccine",

author = "Sajid Hameed and Khan, {Ayisha Farooq} and Sara Khan and Mohammad Wasay",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2022",

month = mar,

doi = "10.1016/j.jstrokecerebrovasdis.2021.106298",

language = "English",

volume = "31",

journal = "Journal of Stroke and Cerebrovascular Diseases",

issn = "1052-3057",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - First report of cerebral venous thrombosis following inactivated-virus covid vaccination (Sinopharm and Sinovac)

AU - Hameed, Sajid

AU - Khan, Ayisha Farooq

AU - Khan, Sara

AU - Wasay, Mohammad

PY - 2022/3

Y1 - 2022/3

N2 - Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.

AB - Cerebral venous thrombosis (CVT) is an uncommon cerebrovascular disease, which has been reported with covid infection as well as covid vaccines, particularly AstraZeneca and Janssen vaccines. We present four consecutive cases of CVT after receiving either Sinopharm or Sinovac vaccine, both of which are composed of an inactivated-virus. All the patients recovered well with anticoagulation and discharged with a good functional outcome. This is the first case series reporting CVT following the administration of these vaccines.

KW - CVT

KW - Cerebral venous thrombosis

KW - Sinopharm

KW - Sinovac

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85122626487&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2021.106298

DO - 10.1016/j.jstrokecerebrovasdis.2021.106298

M3 - Article

C2 - 35033989

AN - SCOPUS:85122626487

SN - 1052-3057

VL - 31

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

IS - 3

M1 - 106298

ER -

First report of cerebral venous thrombosis following inactivated-virus covid vaccination (Sinopharm and Sinovac)

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this